Literature DB >> 24904022

Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D.

Minjoo Kim1, Se Ri Jeung2, Tae-Sook Jeong3, Sang-Hyun Lee4, Jong Ho Lee5.   

Abstract

To determine dietary effects on circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) activity and enzyme activity in peripheral blood mononuclear cells (PBMCs), 99 patients with impaired fasting glucose, impaired glucose tolerance, or newly-diagnosed T2D were randomly assigned to either a control group (usual diet with refined rice) or the whole grain and legume group. Substitution of whole grains and legumes for refined rice was associated with the replacement of 7% of energy from carbohydrates with energy from protein (about 4%) and fat. After 12 weeks, the whole grain and legume group showed a significant decrease in fasting glucose, insulin, homeostasis model assessment-insulin resistance, hemoglobin A1c, malondialdehyde, plasma Lp-PLA2 activity, and oxidized LDL (ox-LDL), and an increase in LDL particle size. The changes (Δs) in these variables in the whole grain and legume group were significantly different from those in controls after adjustment for the baseline levels. When all subjects were considered, Δ plasma Lp-PLA2 positively correlated with Δ glucose, Δ PBMC Lp-PLA2, Δ ox-LDL, and Δ urinary 8-epi-prostaglandin F2α after being adjusted for confounding factors. The Δ PBMC Lp-PLA2 correlated positively with Δ glucose and Δ ox-LDL, and negatively with Δ LDL particle size and baseline PBMC Lp-PLA2 The substitution of whole grains and legumes for refined rice resulted in a reduction in Lp-PLA2 activities in plasma and PBMCs partly through improved glycemic control, increased consumption of protein relative to carbohydrate, and reduced lipid peroxides.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  lipoprotein-associated phospholipase A2; peripheral blood mononuclear cell; type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 24904022      PMCID: PMC4109770          DOI: 10.1194/jlr.M044834

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

1.  Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.

Authors:  K L Carpenter; I F Dennis; I R Challis; D P Osborn; C H Macphee; D S Leake; M J Arends; M J Mitchinson
Journal:  FEBS Lett       Date:  2001-09-21       Impact factor: 4.124

2.  Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.

Authors:  Yi Shi; Ping Zhang; LiFeng Zhang; Hashim Osman; Emile R Mohler; Colin Macphee; Andrew Zalewski; Anthony Postle; Robert L Wilensky
Journal:  Atherosclerosis       Date:  2006-06-09       Impact factor: 5.162

3.  Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.

Authors:  Irene Gazi; Evangelia S Lourida; Theodosios Filippatos; Vasilis Tsimihodimos; Moses Elisaf; Alexandros D Tselepis
Journal:  Clin Chem       Date:  2005-10-13       Impact factor: 8.327

4.  Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.

Authors:  M Serban; Cristina Tanaseanu; T Kosaka; Cristina Vidulescu; Irina Stoian; Daciana S Marta; S Tanaseanu; Elena Moldoveanu
Journal:  J Cell Mol Med       Date:  2002 Oct-Dec       Impact factor: 5.310

5.  Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Authors:  Marc S Sabatine; David A Morrow; Michelle O'Donoghue; Kathleen A Jablonksi; Madeline Murguia Rice; Scott Solomon; Yves Rosenberg; Michael J Domanski; Judith Hsia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-31       Impact factor: 8.311

6.  Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

Authors:  U P Steinbrecher; P H Pritchard
Journal:  J Lipid Res       Date:  1989-03       Impact factor: 5.922

7.  Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.

Authors:  Sotirios Tsimikas; Johann Willeit; Michael Knoflach; Manuel Mayr; Georg Egger; Marlene Notdurfter; Joseph L Witztum; Christian J Wiedermann; Qingbo Xu; Stefan Kiechl
Journal:  Eur Heart J       Date:  2008-11-19       Impact factor: 29.983

8.  The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.

Authors:  Stephan von Haehling; Sabine Genth-Zotz; Rakesh Sharma; Aidan P Bolger; Wolfram Doehner; Peter J Barnes; Andrew J S Coats; Stefan D Anker
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

9.  Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.

Authors:  Ida J Hatoum; Jeanenne J Nelson; Nancy R Cook; Frank B Hu; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2010-01-27       Impact factor: 7.045

Review 10.  The potential role of phytochemicals in wholegrain cereals for the prevention of type-2 diabetes.

Authors:  Damien P Belobrajdic; Anthony R Bird
Journal:  Nutr J       Date:  2013-05-16       Impact factor: 3.271

View more
  8 in total

1.  Replacing carbohydrate with protein and fat in prediabetes or type-2 diabetes: greater effect on metabolites in PBMC than plasma.

Authors:  Minjoo Kim; Gayoung Song; Miso Kang; Hye Jin Yoo; Tae-Sook Jeong; Sang-Hyun Lee; Jong Ho Lee
Journal:  Nutr Metab (Lond)       Date:  2016-01-19       Impact factor: 4.169

Review 2.  Glycemic Index (GI) or Glycemic Load (GL) and Dietary Interventions for Optimizing Postprandial Hyperglycemia in Patients with T2 Diabetes: A Review.

Authors:  Dionysios Vlachos; Sofia Malisova; Fedon A Lindberg; Georgia Karaniki
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

Review 3.  Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism.

Authors:  Paraskevi Detopoulou; Constantinos A Demopoulos; Smaragdi Antonopoulou
Journal:  Nutrients       Date:  2021-01-30       Impact factor: 5.717

4.  The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review.

Authors:  Carolyn J English; Hannah L Mayr; Anna E Lohning; Dianne P Reidlinger
Journal:  Nutr Rev       Date:  2022-05-09       Impact factor: 6.846

5.  Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial.

Authors:  Maria Detopoulou; Agathi Ntzouvani; Filio Petsini; Labrini Gavriil; Elizabeth Fragopoulou; Smaragdi Antonopoulou
Journal:  Biomolecules       Date:  2021-05-28

6.  Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses.

Authors:  Andrew N Reynolds; Ashley P Akerman; Jim Mann
Journal:  PLoS Med       Date:  2020-03-06       Impact factor: 11.069

Review 7.  Nutritional Strategies in Prediabetes: A Scoping Review of Recent Evidence.

Authors:  Jun Wern Yau; Sze Mun Thor; Amutha Ramadas
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

8.  Pulse consumption improves indices of glycemic control in adults with and without type 2 diabetes: a systematic review and meta-analysis of acute and long-term randomized controlled trials.

Authors:  Maryam S Hafiz; Matthew D Campbell; Lauren L O'Mahoney; Melvin Holmes; Caroline Orfila; Christine Boesch
Journal:  Eur J Nutr       Date:  2021-09-29       Impact factor: 5.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.